aHUS

Related by string. Ahu . AHU . ahu . Ahued . Ahus * * O ` ahu . Secretary Armando Ahued . Dr. Armando Ahued . Te Ahu . Te Ahu Davis . Armando Ahued . Lei Ahu Isa . Ahus Sweden . Ahu Hetman hospital *

Related by context. Frequent words. (Click for all words.) 67 lupus nephritis 63 chronic ITP 62 hypercalcemia 62 metastatic renal cell carcinoma 62 systemic lupus erythematosus 62 myelodysplastic syndromes MDS 62 chronic HCV infection 62 myelofibrosis 61 chronic lymphocytic leukemia CLL 61 relapsing remitting multiple sclerosis 61 idiopathic pulmonary fibrosis IPF 61 systemic lupus erythematosus SLE 61 eculizumab 61 GvHD 61 infantile spasms 61 TORISEL 61 acute myeloid leukemia AML 61 immunocompromised patients 60 B CLL 60 myelodysplastic syndromes 60 hypoparathyroidism 60 relapsed multiple myeloma 60 mixed dyslipidemia 60 chronic renal failure 60 nilotinib 59 Cushing syndrome 59 unresectable 59 neuroendocrine tumors 59 Torisel 59 cutaneous T cell 59 chronic myeloid leukemia CML 59 immunodeficiency 59 hepatocellular carcinoma HCC 58 hemolytic anemia 58 allogeneic stem cell 58 stable angina 58 pulmonary arterial hypertension PAH 58 nephrotic syndrome 58 acute ischemic stroke 58 soft tissue sarcomas 58 azacitidine 58 beta thalassemia 58 diabetic macular edema DME 58 relapsing remitting 58 chronic HCV 57 mCRC 57 uveitis 57 acromegaly 57 hepatic encephalopathy 57 severe sepsis 57 angioedema 57 hyperuricemia 57 hormone refractory prostate cancer 57 diabetic nephropathy 57 pulmonary arterial hypertension 57 dasatinib 57 nephropathy 57 short bowel syndrome 57 hematologic malignancies 57 diabetic neuropathic pain 57 methylnaltrexone 57 cardiogenic shock 56 HCV infection 56 CA4P 56 acute myocardial infarction AMI 56 relapsing remitting MS 56 hepatotoxicity 56 refractory multiple myeloma 56 hematological 56 hematological malignancies 56 castration resistant prostate cancer 56 immunosuppressed 56 left ventricular dysfunction 56 hepatocellular carcinoma 56 HRPC 56 thromboembolic events 56 renal disease 56 Cimzia ® 56 severe renal impairment 56 TELCYTA 56 renal insufficiency 56 clofarabine 56 sunitinib 56 myelodysplastic syndrome 56 investigational compounds 56 biologic therapy 56 NSCLC 56 DMARDs 56 dose cohorts 56 cSSSI 56 Gaucher disease 56 bosentan 56 sarcomas 56 RRMS 55 Phase 2b trial 55 dose regimens 55 tyrosine kinase inhibitors 55 ventricular tachycardia 55 Miraxion 55 velaglucerase alfa 55 renal cell carcinoma

Back to home page